Frequently asked questions: coronavirus (COVID-19) and lupus

May is Lupus Awareness Month. It is a disease that is relatively common in the Caribbean yet many of us are unfamiliar with the condition. Lupus is an autoimmune condition that can affect almost every system

ImmuPharma PLC (LON:IMM, the specialist drug discovery and development company, has announced that it has entered into agreements with two specialist US healthcare investors for a total investment of up to $6.30 million (£4.94 million) comprising an

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today announced that with immediate effect, its registered office address has been changed to: One Bartholomew Close, London, EC1A 7BL.

Women who have gone through the trauma of having a stillbirth are four times more likely to develop Lupus than women with an uncomplicated livebirth, according to a University of Manchester study. The researchers found a

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, today announced that the Company’s Annual General Meeting confirmed for Thursday, 18 June 2020 @ 10.30am, will now be held at: 52 Grosvenor Garden, London SW1W 0AU. The COVID-19

Lupus is a relatively rare inflammatory disease. In the US 1.5 million are currently living with the condition. It is an autoimmune disease that can affect various organs including the skin, joints, kidneys, and brain. What

A song of hope dubbed ‘At the mention of your name’ has been released to commemorate the 17th global observance of World Lupus Day in Accra. “The song is dedicated to all lupus warriors around the world.

US singer Selena Gomez has urged her fans across the world to join the fight against Lupus, an autoimmune disease. The disease leads to the body’s immune system becoming hyperactive, attacking normal and healthy tissues. On

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, today provided a progress update on activities around Covid-19. On 30 March 2020, ImmuPharma announced that it had expanded its pipeline to include three new ‘Anti-Infective’

Lupus is a chronic (long-term) disease that can cause inflammation and pain in any part of your body. It’s an autoimmune disease, which means that your immune system — the body system that usually fights infections

ImmuPharma plc (LON:IMM), the specialist drug discovery and development company, is pleased to announce its final results for the twelve months ended 31 December 2019. Key Highlights (including post Period review) ·    Stable financial performance over the Period

Lupus is a chronic autoimmune condition in which the immune system attacks its own tissues. People with lupus are at higher risk of infections, and those with lupus who develop COVID-19 may be at higher risk

Researchers suggest maintaining disease remission in people with lupus, especially during a pandemic infection, is extremely important to avoid unnecessary office and emergency room visits, and hospitalizations, all of which increase potential exposure to COVID-19. People with lupus

There is no evidence that taking hydroxychloroquine (Plaquenil) is effective in preventing a person from contracting the coronavirus (COVID-19). People with lupus should follow the guidance of their doctor and the safety guidelines being issued by

A 2-year, sustained mean blood pressure of 130-139/80-89 mm Hg — now considered the threshold for stage 1 hypertension by the American College of Cardiology and the American Heart Association — is associated with a 73%

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today announced subscriptions to raise £1.5 million through the issue of 15,000,000 new ordinary share of 10 pence each in the Company at a price

Lupus isn’t that common but when it strikes it can be very ­serious, even life-threatening. The story of the singer and ­actress Selena Gomez is a case in point. All lupus sufferers will be grateful to her because

When you are not feeling well, all you want to do is pinpoint why and get proper treatment. For patients with lupus, however, the journey to a correct diagnosis can be especially frustrating. An estimated 1.5